☆ 4.6 Letter

A Europe-Wide assessment of current medication choices in Huntington's disease

MOVEMENT DISORDERS (2008)

Journal

MOVEMENT DISORDERS

Volume 23, Issue 12, Pages 1788-1788

Publisher

WILEY-LISS

DOI: 10.1002/mds.22188

Keywords

-

Categories

Clinical Neurology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Clinical Neurology

Psychotropic medication use in Huntington's disease: A retrospective cohort study

Ruben L. Andriessen, Mayke Oosterloo, Angelique Hollands, David E. J. Linden, Bianca T. A. de Greef, Albert F. G. Leentjens

Summary: The study found that psychotropic medication is widely prescribed in HD patients, with antidepressant use decreasing proportionally and antipsychotic use increasing with advancing disease stages. This suggests a relative decrease in prevalence of anxiety and depression, and a relative increase in irritability and delusions over disease stages.

PARKINSONISM & RELATED DISORDERS (2022)

Add to Collection

Article Clinical Neurology

Measuring cognitive impairment and monitoring cognitive decline in Huntington's disease: a comparison of assessment instruments

Andrea Horta-Barba, Saul Martinez-Horta, Jesus Perez-Perez, Arnau Puig-Davi, Natascia de Lucia, Giuseppe de Michele, Elena Salvatore, Stefanie Kehrer, Josef Priller, Simone Migliore, Ferdinando Squitieri, Anna Castaldo, Caterina Mariotti, Veronica Mananes, Jose Luis Lopez-Sendon, Noelia Rodriguez, Asuncion Martinez-Descals, Filipa Julio, Cristina Januario, Marianna Delussi, Marina de Tommaso, Sandra Noguera, Jesus J. Ruiz-Idiago, Emilia Sitek, Renata Wallner, Angela Nuzzi, Javier Pagonabarraga, Jaime Kulisevsky

Summary: This study developed a specific assessment tool, the Parkinson's Disease-Cognitive Rating Scale (PD-CRS), to evaluate the cognitive status of Huntington's disease patients and monitor the progression of cognitive impairment. Through evaluating 180 gene-positive patients, criteria for classifying normal cognition, mild cognitive impairment, and dementia were established, and the PD-CRS demonstrated good sensitivity and specificity. Additionally, the PD-CRS captured cognitive progression in different cognitive groups and showed sensitivity to change in mild cognitive impairment and dementia.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Article Psychology, Multidisciplinary

Diagnostic properties of the Frontal Assessment Battery (FAB) in Huntington's disease

Federica Solca, Edoardo Nicolo Aiello, Simone Migliore, Silvia Torre, Laura Carelli, Roberta Ferrucci, Alberto Priori, Federico Verde, Nicola Ticozzi, Sabrina Maffi, Consuelo Ceccarelli, Ferdinando Squitieri, Vincenzo Silani, Andrea Ciammola, Barbara Poletti

Summary: This study assessed the diagnostic properties of the Frontal Assessment Battery (FAB) in discriminating HD patients from HCs and identifying cognitive impairment in HD patients. The results showed that the FAB had good discriminative and diagnostic abilities and could be used effectively for cognitive screening in HD patients.

FRONTIERS IN PSYCHOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Vitamin D status in chimpanzees in human care: a Europe wide study

Sophie Moittie, Rachel Jarvis, Stephan Bandelow, Sarah Byrne, Phillipa Dobbs, Melissa Grant, Christopher Reeves, Kate White, Matyas Liptovszky, Kerstin Baiker

Summary: This study investigated the vitamin D levels in chimpanzees housed in 32 European zoos, with 33.1% of the samples showing inadequate vitamin D levels. It is recommended to review the husbandry and nutrition practices to ensure optimal vitamin D supply for these endangered animals.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Clinical Neurology

Medial prefrontal transcranial alternating current stimulation for apathy in Huntington's disease

Marie-Claire Davis, Aron T. Hill, Paul B. Fitzgerald, Neil W. Bailey, Caley Sullivan, Julie C. Stout, Kate E. Hoy

Summary: This study investigated the effects of transcranial alternating current stimulation (tACS) on brain activity and apathy in people with Huntington's disease (HD) and neurotypical controls. The results showed that alpha-tACS increased CNV amplitude in HD participants, indicating modulation of brain activity associated with apathy. In neurotypical controls, alpha-tACS led to a decreased post-target response time. These findings suggest the potential of alpha-tACS in modulating brain activity and improving apathy in HD.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development

Jingyun Wu, Luisa Mohle, Thomas Bruning, Ivan Eiriz, Muhammad Rafehi, Katja Stefan, Sven Marcel Stefan, Jens Pahnke

Summary: This study describes the generation of a new mouse model, zQ175(Delta neo), by excising the neomycin resistance cassette, and provides a comprehensive characterization of the behavioral, neuropathological, and immunohistological changes in this model. Furthermore, the study collects and analyzes the bioactivity network of small-molecule HD modulators, identifying numerous compounds targeting different pharmacological targets and pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Food Science & Technology

Implementation of harmonised epidemiological indicators (HEIs) for pigs-A Europe-wide online survey

Ting-Ting Li, Susann Langforth, Nina Langkabel, Smaragda Sotiraki, Sofia Anastasiadou, Truls Nesbakken, Diana Meemken

Summary: In 2011, the EFSA introduced harmonised epidemiological indicators for pigs to be used in risk-based meat inspection. However, the application of these indicators is not regulated by law. A questionnaire was developed to evaluate the current implementation of these indicators in Europe, and the results showed that they are underutilised for pigs.

FOOD CONTROL (2023)

Add to Collection

Article Clinical Neurology

Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington's Disease

Nina M. Mansoor, Tishok Vanniyasingam, Ian Malone, Nicola Z. Hobbs, Elin Rees, Alexandra Durr, Raymund A. C. Roos, Bernhard Landwehrmeyer, Sarah J. Tabrizi, Eileanoir B. Johnson, Rachael I. Scahill

Summary: This study compared the performance of four automated segmentation tools with manual delineation in generating caudate volume in early Huntington's disease patients. The results showed significant group differences in volume measurements, with STEPS performing best in both qualitative and quantitative analysis. The study suggests that automated pipelines could be used to generate outcome measures for clinical trials.

FRONTIERS IN NEUROLOGY (2021)

Add to Collection

Review Genetics & Heredity

Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington's Disease

Miguel Pellegrini, Guendalina Bergonzoni, Federica Perrone, Ferdinando Squitieri, Marta Biagioli

Summary: RNA transcription is frequently altered in pathological conditions, including non-coding RNA which have regulatory functions in cellular processes. These RNAs are being evaluated as potential disease biomarkers, especially in neurological and genetic disorders, to aid in diagnosis and treatment development.

GENES (2022)

Add to Collection

Article Food Science & Technology

Specific Avenin Cross-Reactivity with G12 Antibody in a Wide Range of Current Oat Cultivars

Vaclav Dvoracek, Anna Kotrbova-Kozak, Jana Kozova-Dolezalova, Michal Jagr, Petra Hlasna Cepkova, Pavel Vitamvas, Klara Kosova

Summary: Current clinical studies confirm the safety of consuming oats for people with celiac disease, although different oat cultivars show varying levels of immunoreactive gluten epitopes. The study aimed to map cross-reactive oat epitopes in 132 oat cultivars using a G12-based ELISA kit, revealing annual and varietal differences in interference with the G12 antibody. While there was high year-to-year variability in 2/3 of the cultivars, the content of interfering avenin epitopes did not exceed the safe limit for celiacs.

FOODS (2022)

Add to Collection

Review Clinical Neurology

Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study

Idaira Rodriguez-Santana, Tiago Mestre, Ferdinando Squitieri, Rosa Willock, Astri Arnesen, Alison Clarke, Barbara D'Alessio, Alex Fisher, Rebecca Fuller, Jamie L. Hamilton, Hayley Hubberstey, Cath Stanley, Louise Vetter, Michaela Winkelmann, Maria Doherty, Yunchou Wu, Alan Finnegan, Samuel Frank

Summary: This study estimates the economic burden of Huntington disease (HD) by analyzing the direct medical, nonmedical, and indirect costs associated with HD based on the Huntington's Disease Burden of Illness (HDBOI) study. The results show that the economic burden for individuals with HD and their caregivers increases as the disease progresses.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Add to Collection

Article Clinical Neurology

Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe

Marina Boccardi, Andreas U. Monsch, Clarissa Ferrari, Daniele Altomare, Manfred Berres, Isabelle Bos, Andreas Buchmann, Chiara Cerami, Mira Didic, Cristina Festari, Valentina Nicolosi, Leonardo Sacco, Liesbeth Aerts, Emiliano Albanese, Jean-Marie Annoni, Nicola Ballhausen, Christian Chicherio, Jean-Francois Demonet, Virginie Descloux, Suzie Diener, Daniel Ferreira, Jean Georges, Anton Gietl, Nicola Girtler, Ingo Kilimann, Stefan Kloppel, Nicole Kustyniuk, Patrizia Mecocci, Nathalie Mella, Martina Pigliautile, Katrin Seeher, Steven D. Shirk, Alessio Toraldo, Andrea Brioschi-Guevara, Kwun C. G. Chan, Paul K. Crane, Alessandra Dodich, Alice Grazia, Nicole A. Kochan, Fabricio Ferreira de Oliveira, Flavio Nobili, Walter Kukull, Oliver Peters, Inez Ramakers, Perminder S. Sachdev, Stefan Teipel, Pieter Jelle Visser, Michael Wagner, Sandra Weintraub, Eric Westman, Lutz Froelich, Henry Brodaty, Bruno Dubois, Stefano F. Cappa, David Salmon, Bengt Winblad, Giovanni B. Frisoni, Matthias Kliegel

Summary: An expert consensus has been reached on harmonizing the diagnosis of neurocognitive disorders across European countries and potentially beyond, by defining a standardized assessment battery and methodology for obtaining consistent normative data.

ALZHEIMERS & DEMENTIA (2022)

Add to Collection

Article Neurosciences

Dynamics of Cortical Degeneration Over a Decade in Huntington's Disease

Eileanoir B. Johnson, Gabriel Ziegler, William Penny, Geraint Rees, Sarah J. Tabrizi, Rachael Scahill, Sarah Gregory

Summary: The study revealed regional variability in the spatial pattern of cortical atrophy in HD gene carriers, which is related to genetic factors and motor and cognitive symptoms. The findings indicate a complex pattern of neuronal loss, enabling a greater understanding of HD progression.

BIOLOGICAL PSYCHIATRY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Tau: a biomarker of Huntington's disease

Eva Lepinay, Francesca Cicchetti

Summary: Developing effective treatments for Huntington's disease is challenging, and finding robust biomarkers is crucial for diagnosis and treatment.

MOLECULAR PSYCHIATRY (2023)

Add to Collection

Review Public, Environmental & Occupational Health

Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices

Periklis Charalampous, Juanita A. Haagsma, Lea S. Jakobsen, Vanessa Gorasso, Isabel Noguer, Alicia Padron-Monedero, Rodrigo Sarmiento, Joao Vasco Santos, Scott A. McDonald, Dietrich Plass, Grant M. A. Wyper, Ricardo Assuncao, Elena von der Lippe, Balazs Adam, Ala'a AlKerwi, Jalal Arabloo, Ana Lucia Baltazar, Boris Bikbov, Maria Borrell-Pages, Iris Brus, Genc Burazeri, Serafeim C. Chaintoutis, Jose Chen-Xu, Nino Chkhaberidze, Seila Cilovic-Lagarija, Barbara Corso, Sarah Cuschieri, Carlotta Di Bari, Keren Dopelt, Mary Economou, Theophilus Emeto, Peter Fantke, Florian Fischer, Alberto Freitas, Juan Manuel Garcia-Gonzalez, Federica Gazzelloni, Mika Gissler, Artemis Gkitakou, Hakan Gulmez, Sezgin Gunes, Sebastian Haller, Romana Haneef, Cesar A. Hincapie, Paul Hynds, Jane Idavain, Milena Ilic, Irena Ilic, Gaetano Isola, Zubair Kabir, Maria Kamusheva, Pavel Kolkhir, Naime Meric Konar, Polychronis Kostoulas, Mukhtar Kulimbet, Carlo La Vecchia, Paolo Lauriola, Miriam Levi, Marjeta Majer, Enkeleint A. Mechili, Lorenzo Monasta, Stefania Mondello, Javier Munoz Laguna, Evangelia Nena, Edmond S. W. Ng, Paul Nguewa, Vikram Niranjan, Iskra Alexandra Nola, Ronan O'Caoimh, Marija Obradovic, Elena Pallari, Mariana Peyroteo, Vera Pinheiro, Nurka Pranjic, Miguel Reina Ortiz, Silvia Riva, Cornelia Melinda Adi Santoso, Milena Santric Milicevic, Tugce Schmitt, Niko Speybroeck, Maximilian Sprugel, Paschalis Steiropoulos, Aleksandar Stevanovic, Lau Caspar Thygesen, Fimka Tozija, Brigid Unim, Hilal Bektas Uysal, Orsolya Varga, Milena Vasic, Rafael Jose Vieira, Vahit Yigit, Brecht Devleesschauwer, Sara M. Pires

Summary: This systematic literature review provides an overview of studies applying the disability-adjusted life years (DALY) concept for infectious diseases in European countries. Among the 105 included studies, food- and water-borne diseases were the most frequently studied. The number of burden of infectious disease studies has increased over time, but there is less consensus in methodological approaches.

EPIDEMIOLOGY AND INFECTION (2023)

Add to Collection

Article Clinical Neurology

Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers

Frank Jessen, Steffen Wolfsgruber, Luca Kleineindam, Annika Spottke, Slawek Altenstein, Claudia Bartels, Moritz Berger, Frederic Brosseron, Marcel Daamen, Martin Dichgans, Laura Dobisch, Michael Ewers, Friederike Fenski, Klaus Fliessbach, Silka D. Freiesleben, Wenzel Glanz, Doreen Goerss, Selim Guersel, Daniel Janowitz, Ingo Kilimann, Xenia Kobeleva, Andrea Lohse, Franziska Maier, Coraline Metzger, Matthias Munk, Lukas Preis, Carolin Sanzenbacher, Eike Spruth, Boris Rauchmann, Ruth Vukovich, Renat Yakupov, Anne-Sophie Weyrauch, Gabriel Ziegler, Matthias Schmid, Christoph Laske, Robert Perneczky, Anja Schneider, Jens Wiltfang, Stefan Teipel, Katharina Buerger, Josef Priller, Oliver Peters, Alfredo Ramirez, Henning Boecker, Michael T. Heneka, Michael Wagner, Emrah Duezel

Summary: Research finds that subjective cognitive decline (SCD) in individuals who seek medical help may serve as an initial symptomatic stage 2 of the Alzheimer's disease (AD) continuum. The SCD group shows slightly worse cognition, as well as more subtle functional and behavioral symptoms compared to the control group (CO). It is also discovered that SCD-A+ cases (39.3% of all SCD) exhibit greater hippocampal atrophy, lower cognitive and functional performance, and more behavioral symptoms.

ALZHEIMERS & DEMENTIA (2023)

Add to Collection

Article Clinical Neurology

Negative symptoms, striatal dopamine and model-free reward decision-making in schizophrenia

Felix Brandl, Franziska Knolle, Mihai Avram, Claudia Leucht, Igor Yakushev, Josef Priller, Stefan Leucht, Sibylle Ziegler, Klaus Wunderlich, Christian Sorg

Summary: Negative symptoms in patients with schizophrenia are highly prevalent and debilitating. This study found that impaired model-free reward prediction influence is a mechanism for negative symptoms in schizophrenia, and it is associated with reduced associative striatum dopamine and executive dysfunction.

BRAIN (2023)

Add to Collection

Article Neurosciences

Defining the pig microglial transcriptome reveals its core signature, regional heterogeneity, and similarity with human and rodent microglia

Barbara B. Shih, Sarah M. Brown, Jack Barrington, Lucas Lefevre, Neil A. Mabbott, Josef Priller, Gerard Thompson, Alistair B. Lawrence, Barry W. McColl

Summary: Microglia from pig show a core microglial signature that is conserved across species, but species-specific expression subsets also exist. This study provides valuable insights for using pigs as a large animal model to study the role of microglia during homeostasis and disease.

GLIA (2023)

Add to Collection

Article Clinical Neurology

Herpes simplex virus alters Alzheimer's disease biomarkers - A hypothesis paper

Oliver Goldhardt, Robert Freiberger, Tobias Dreyer, Luisa Willner, Igor Yakushev, Marion Ortner, Hans Foerstl, Janine Diehl-Schmid, Esther Milz, Josef Priller, Alfredo Ramirez, Viktor Magdolen, Markus Thaler, Timo Grimmer

Summary: This study investigated the association between HSV infection and AD biomarkers. The results suggest that in HSV1-seropositive AD patients, there is a significant predictive effect of AI-IgG(HSV1/2) and Aβ(42)/Aβ(40) ratio on pTau.

ALZHEIMERS & DEMENTIA (2023)

Add to Collection

Article Clinical Neurology

Speech biomarkers in Huntington's disease: A cross-sectional study in pre-symptomatic, prodromal and early manifest stages

Tomas Kouba, Wiebke Frank, Tereza Tykalova, Alzbeta Muehlbaeck, Jiri Klempir, Katrin S. Lindenberg, G. Bernhard Landwehrmeyer, Jan Rusz

Summary: This study examined speech alterations in patients with Huntington's disease (HD) using objective acoustic analysis. The results showed that these speech alterations were associated with other motor and cognitive deficits. The study also found that acoustic analysis can reliably detect speech alterations in the early stages of HD.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Add to Collection

Review Clinical Neurology

Quality of life, health-related quality of life, and associated factors in Huntington's disease: a systematic review

Pearl J. C. van Lonkhuizen, Wiebke Frank, Anne-Wil Heemskerk, Erik van Duijn, Susanne de Bot, Alzbeta Muehlbaeck, G. Bernhard Landwehrmeyer, Niels Chavannes, Eline Meijer

Summary: This systematic review examined self-reported health-related quality of life (HRQoL) in individuals with Huntington's disease, and identified factors and interventions associated with HRQoL. The findings suggest that individuals with Huntington's disease have lower HRQoL and several factors contribute to this, including depressive symptoms and lower support. Multidisciplinary rehabilitation programs and respiratory muscle training are beneficial for improving HRQoL.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Article Geriatrics & Gerontology

Altered retinal cerebral vessel oscillation frequencies in Alzheimer?s disease compatible with impaired amyloid clearance

Konstantin Kotliar, Marion Ortner, Anna Conradi, Patricia Hacker, Christine Hauser, Roman Guenthner, Michaela Moser, Claudia Muggenthaler, Janine Diehl-Schmid, Josef Priller, Christoph Schmaderer, Timo Grimmer

Summary: This study aimed to investigate whether retinal vessel oscillations are altered in Alzheimer's disease (AD) during the stages of dementia and mild cognitive impairment (MCI). The results showed that arterial oscillations at moderately low frequencies significantly prevailed in AD and MCI patients compared to healthy controls, and were correlated with disease severity. This suggests a compensatory upregulation of paravascular drainage in AD and supports the amyloid clearance hypothesis.

NEUROBIOLOGY OF AGING (2022)

Add to Collection

Article Cell & Tissue Engineering

Generation of induced pluripotent stem cells from three individuals with Huntington's disease

Duncan C. Miller, Pawel Lisowski, Selene Lickfett, Barbara Mlody, Miriam Buenning, Carolin Genehr, Claas Ulrich, Erich E. Wanker, Sebastian Diecke, Josef Priller, Alessandro Prigione

Summary: This study generated induced pluripotent stem cells (iPSCs) using non-integrative episomal plasmids from three individuals affected by Huntington's disease (HD), and confirmed their pluripotency, normal karyotype, and ability to differentiate into cells of the three germ layers.

STEM CELL RESEARCH (2022)

Add to Collection

Article Multidisciplinary Sciences

Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer's disease

Camila Fernandez Zapata, Ginevra Giacomello, Eike J. Spruth, Jinte Middeldorp, Gerardina Gallaccio, Adeline Dehlinger, Claudia Dames, Julia K. H. Leman, Roland E. van Dijk, Andreas Meisel, Stephan Schlickeiser, Desiree Kunkel, Elly M. Hol, Friedemann Paul, Maria Kristina Parr, Josef Priller, Chotima Boettcher

Summary: Myeloid cells play an important role in Alzheimer's disease (AD), but their phenotypic and functional changes across different body compartments and their use as biomarkers in AD are still unclear. This study characterizes immune cells from peripheral blood, cerebrospinal fluid, choroid plexus, and brain parenchyma, revealing that AD-myeloid cells show more pronounced changes in phenotype in the choroid plexus and brain parenchyma. These findings highlight the importance of myeloid cells in AD and provide insights for future studies on biomarker assessment.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Endocrinology & Metabolism

Lower hypothalamus subunit volumes link with impaired long-term body weight gain after preterm birth

Tobias Ruzok, Benita Schmitz-Koep, Aurore Menegaux, Robert Eves, Marcel Daamen, Henning Boecker, Esther Rieger-Fackeldey, Josef Priller, Claus Zimmer, Peter Bartmann, Dieter Wolke, Christian Sorg, Dennis M. Hedderich

Summary: Premature birth is associated with an increased risk of impaired body weight gain, potentially due to altered structure of hypothalamic nuclei involved in body weight control.

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection

Article Psychology, Multidisciplinary

Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve

Luca Kleineidam, Steffen Wolfsgruber, Anne-Sophie Weyrauch, Linn E. Zulka, Simon Forstmeier, Sandra Roeske, Hendrik van den Bussche, Hanna Kaduszkiewicz, Birgitt Wiese, Siegfried Weyerer, Jochen Werle, Angela Fuchs, Michael Pentzek, Christian Brettschneider, Hans-Helmut Konig, Dagmar Weeg, Horst Bickel, Melanie Luppa, Francisca S. Rodriguez, Silka Dawn Freiesleben, Selin Erdogan, Chantal Unterfeld, Oliver Peters, Eike J. Spruth, Slawek Altenstein, Andrea Lohse, Josef Priller, Klaus Fliessbach, Xenia Kobeleva, Anja Schneider, Claudia Bartels, Bjoern H. Schott, Jens Wiltfang, Franziska Maier, Wenzel Glanz, Enise I. Incesoy, Michaela Butryn, Emrah Duezel, Katharina Buerger, Daniel Janowitz, Michael Ewers, Boris-Stephan Rauchmann, Robert Perneczky, Ingo Kilimann, Doreen Goerss, Stefan Teipel, Christoph Laske, Matthias H. J. Munk, Annika Spottke, Nina Roy, Frederic Brosseron, Michael T. Heneka, Alfredo Ramirez, Renat Yakupov, Martin Scherer, Wolfgang Maier, Frank Jessen, Steffi G. Riedel-Heller, Michael Wagner

Summary: This study explores the relationship between occupation, cognitive abilities, and brain health throughout a person's lifetime. It suggests that engaging in complex and stimulating work environments can enhance the resistance to pathological changes and reduce the risk of Alzheimer's disease.

FRONTIERS IN PSYCHOLOGY (2022)

Add to Collection

Review Physiology

Dysfunction of circadian and sleep rhythms in the early stages of Alzheimer's disease

Ludovica Rigat, Koliane Ouk, Achim Kramer, Josef Priller

Summary: Dysfunction of circadian and sleep rhythms is observed in the early stages of neurodegenerative diseases like Alzheimer's disease. It is unclear whether these dysfunctions contribute to the disease's development or are a consequence of it, but there is evidence of a complex bidirectional relationship. Recent studies suggest that circadian clock dysregulation occurs early in the disease and may promote neurodegeneration. Restoring sleep and circadian rhythms in preclinical AD could potentially slow the disease progression.

ACTA PHYSIOLOGICA (2023)

Add to Collection

Article Clinical Neurology

Establishing normative data for the evaluation of cognitive performance in Huntington's disease considering the impact of gender, age, language, and education

Alzbeta Muehlbaeck, Josef Mana, Michael Wallner, Wiebke S. Frank, Katrin Lindenberg, Rainer Hoffmann, Olga Klempirova, Jiri Klempir, G. Bernhard Landwehrmeyer, Ondrej Bezdicek

Summary: The study aims to provide appropriate normative data to help clinicians identify disease-associated cognitive decline in diverse HD populations by considering confounding factors such as language, gender, age, and education level.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Article Behavioral Sciences

Progressive alterations in white matter microstructure across the timecourse of Huntington's disease

Carlos Estevez-Fraga, Michael S. Elmalem, Marina Papoutsi, Alexandra Durr, Elin M. Rees, Nicola Z. Hobbs, Raymund A. C. Roos, Bernhard Landwehrmeyer, Blair R. Leavitt, Douglas R. Langbehn, Rachael I. Scahill, Geraint Rees, Sarah J. Tabrizi, Sarah Gregory

Summary: This study investigated the longitudinal changes in white matter microstructure in Huntington's disease and found significant alterations in larger white matter areas as the disease progressed, indicating a progressive deterioration of white matter microstructure with disease evolution.

BRAIN AND BEHAVIOR (2023)

Add to Collection

Article Multidisciplinary Sciences

Cell-autonomous immune dysfunction driven by disrupted autophagy in C9orf72-ALS iPSC-derived microglia contributes to neurodegeneration

Poulomi Banerjee, Arpan R. Mehta, Raja S. Nirujogi, James Cooper, Owen G. James, Jyoti Nanda, James Longden, Karen Burr, Karina McDade, Andrea Salzinger, Evdokia Paza, Judith Newton, David Story, Suvankar Pal, Colin Smith, Dario R. Alessi, Bhuvaneish T. Selvaraj, Josef Priller, Siddharthan Chandran

Summary: Using hiPSC-MG, researchers found that reduced C9ORF72 protein is associated with impaired phagocytosis and an exaggerated immune response. Their findings also revealed dysregulation in myeloid cells as a contributor to neurodegeneration in ALS/FTD, and pharmacological activation of autophagy can ameliorate cell-autonomous functional deficits and motor neuron death in coculture.

SCIENCE ADVANCES (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.